Computational Engineering of siderocalin to modulate its binding affinity to the antihypertension drug candesartan
Journal of Structural Biology · 2025
DOI: 10.1016/j.jsb.2025.108180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Structural Biology, 2025. Verfasst von Kristina Vogel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany. Hauptthemen laut MEDLINE: Benzimidazoles, Tetrazoles, Antihypertensive Agents, Protein Engineering. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCRR NIH HHS, NIDA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Lipocalin family proteins have been shown to bind a vast array of small molecules and have subsequently been adapted to selectively bind specific ligands. In this study, candesartan, an antihypertension drug, was identified to bind mouse and human siderocalin in biomolecular NMR experiments, allowing for structural insights into the candesartan-siderocalin interaction. The ligand binding site was determined through an integrative structural biology approach using in silico ligand docking guided by NMR experiments. Building on this structurally informed binding model, we used rational protein design to modulate the binding pocket for increased or decreased ligand binding affinity. The predicted mutations were evaluated in vitro using isothermal titration calorimetry. This resulted in a mutant with a 50-fold increase in binding affinity in addition to a second mutant with a five-fold decrease in binding affinity. Thus, siderocalins have potential as a scaffold for creation of various ligand binding-based tools, including drug scavengers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany.
- Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Leipzig University, Leipzig, Germany.
- Center for Structural Biology, Vanderbilt University, Nashville, TN, the United States of America; Department of Chemistry, Vanderbilt University, Nashville, TN, the United States of America.
- Institute of Medical Physics and Biophysics, Faculty of Medicine, Leipzig University, Leipzig, Germany.
- Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Leipzig University, Leipzig, Germany; C…
- Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Leipzig University, Leipzig, Germany. E…
Förderung
- NCRR NIH HHS
- NIDA NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- NLM NIH HHS
- Alexander von Humboldt Foundation
- German Research Foundation
- National Institutes of Health
Zitieren
APA
Vogel, K., Moeller, J., Bozhanova, N. G., Voehler, M., Penk, A., Meiler, J., & Schoeder, C. T. (2025). Computational Engineering of siderocalin to modulate its binding affinity to the antihypertension drug candesartan. Journal of Structural Biology. https://doi.org/10.1016/j.jsb.2025.108180
Vancouver
Vogel K, Moeller J, Bozhanova NG, Voehler M, Penk A, Meiler J, et al. Computational Engineering of siderocalin to modulate its binding affinity to the antihypertension drug candesartan. Journal of Structural Biology. 2025. doi:10.1016/j.jsb.2025.108180
BibTeX
@article{Vogel2025,
author = {Vogel, Kristina and Moeller, Johanna and Bozhanova, Nina G and Voehler, Markus and Penk, Anja and Meiler, Jens and Schoeder, Clara T},
title = {Computational Engineering of siderocalin to modulate its binding affinity to the antihypertension drug candesartan},
journal = {Journal of Structural Biology},
year = {2025},
doi = {10.1016/j.jsb.2025.108180}
}
EUVIMED